vimarsana.com
Home
Live Updates
Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss o
Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss o
Phase 2 Study Demonstrates Oral Rilzabrutinib Reduces Loss of Control Events in Patients With Asthma
According to the investigators, these findings support the investigation of rilzabrutinib in patients with asthma in a phase 3 trial program.
Related Keywords
San Diego ,
California ,
United States ,
Boston ,
Massachusetts ,
American ,
Tanyam Laidlaw ,
Phouman Ashrafian ,
Translational Research In Allergy ,
American Thoracic Society International Conference ,
Laidlaw ,
Thoracic Society International Conference ,
Concept Study ,
Adult Participants With Moderate To Severe ,
Translational Research ,
Asthma Control ,
Media Update ,
Press Release ,